Fibroblast growth factor 23 is increased in calcium nephrolithiasis with hypophosphatemia and renal phosphate leak

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 3, 2006, Pages 959-963

  Rendina, Domenico ^a   Mossetti, Giuseppe ^a,d   De Filippo, Gianpaolo ^b   Cioffi, Michele ^c   Strazzullo, Pasquale ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b G RUMMO HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE;

ADULT; ARTICLE; CALCIUM STONE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHOSPHATEMIA; KIDNEY TUBULE ABSORPTION; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; OSTEOMALACIA; PARATHYROID FUNCTION; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REFERENCE VALUE; VITAMIN D RESISTANT RICKETS; X CHROMOSOME LINKAGE;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CALCIFEDIOL; CALCITRIOL; CALCIUM; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; HYPOPHOSPHATEMIA; KIDNEY CALCULI; MALE; PHOSPHATES; PROSPECTIVE STUDIES; REFERENCE VALUES;

EID: 33644816123     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1606     Document Type: Article

References (20)

1. Pak CY 1998 Kidney stones. Lancet 351:1797-1801
2. Prié D, Ravery V, Boccon-Gibod L, Friedlander G 2001 Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 60:272-276
3. Hess B, Tiselius HG 2002 Physical-chemical process in kidney stone formation. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 619-628
4. Prié D, Beck L, Silve C, Friedlander G 2004 Hypophosphatemia and calcium nephrolithiasis. Nephron Exp Nephrol 98:e50-e54
5. Quarles LD 2003 FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab 285:E1-E9
6. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T 2004 FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429-435
7. Ferrari SL, Bonjour JP, Rizzoli R 2005 Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519-1524
8. Larsson T, Yu X, Davis SI, Draman MS, Mooney SD, Cullen MJ, White KE 2005 A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab 90:2424-2427
9. Jan de Beur SM 2005 Tumoral calcinosis: a look into the metabolic mirror of phosphate homeostasis. J Clin Endocrinol Metab 90:2469-2471
10. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H 2003 Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656-1663
11. Lash JP, Cowell G, Arruda JAL 2002 Calcium nephrolithiasis and renal tubular acidosis In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. Philadelphia: Lippincott Williams & Wilkins; 717-740
12. Siener R, Hesse A 2002 The effects of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects. Eur Urol 42:289-296
13. Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Gallucci M 2001 Guidelines on urolithiasis. Eur Urol 40:362-471
14. Walton RJ, Bijvoet OL 1975 Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309-310
15. Larsson T, Davis SI, Garringer HJ, Mooney SD, Draman MS, Cullen MJ, White KE 2005 Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed. Endocrinology 146:3883-3891
16. Weber TJ, Liu S, Indridason OS, Quarles LD 2003 Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18:1227-1234
17. Rendina D, Mossetti G, Viceconti R, Sorrentino M, Castaldo R, Manno G, Guadagno V, Strazzullo P, Nunziata V 2004 Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone forming patients. Urology 64:833-838
18. Prié D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G 2002 Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 347:983-991
19. Glantz SA 2001 Primer of biostatistics. New York: McGraw-Hill/Appleton, Lange
20. Yan X, Yokote H, Jing X, Yao L, Sawada T, Zhang Y, Liang S, Sakaguchi K 2005 Fibroblast growth factor 23 reduces expression of type IIa Na+/Pi cotransporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells. Genes Cells 10:489-502